A Trial of Radial EBUS Versus VBN for the Peripheral Pulmonary Lesions
Multicenter, Open-label, Prospective Randomized Controlled Trial of Radial Endobronchial Ultrasonography and Virtual Bronchoscopy Navigation for the Peripheral Pulmonary Lesions
1 other identifier
interventional
300
1 country
6
Brief Summary
Peripheral pulmonary lesions are of growing importance in respiratory field. Early detection of lung cancer, tuberculosis and other diseases often needs a bronchoscopic investigation with different types of navigation. Current randomized clinical study is intended to compare three different modalities of navigation in bronchial tree - virtual bronchoscopy (VBN), radial endobronchial ultrasound (EBUS) and combination of both techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Feb 2022
Typical duration for not_applicable lung-cancer
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 4, 2022
CompletedFirst Posted
Study publicly available on registry
February 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedFebruary 6, 2024
February 1, 2024
2.8 years
February 4, 2022
February 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Efficacy of navigational bronchoscopy in each study arm
Incidence of final diagnoses confirmed by navigational bronchoscopy for each study arm
At the end of study enrollment
Secondary Outcomes (1)
Efficacy of each endoscopic biopsy modality in confirmation of final diagnosis
At the end of study enrollment
Other Outcomes (1)
Safety profile of each study arm
At the end of study enrollment
Study Arms (3)
VBN
EXPERIMENTALVirtual bronchoscopy
VBN+rEBUS
EXPERIMENTALCombination of VBN and radial EBUS
rEBUS
ACTIVE COMPARATORRadial EBUS as a gold standard
Interventions
It is planned to use VBN as the only navigation technique to compare it with rEBUS
It is planned to use rEBUS as the only navigation technique to compare it with VBN
Eligibility Criteria
You may qualify if:
- Patients with newly diagnosed unverified solitary or multiple (up to 3) peripheral pulmonary lesions (PPLs)
- PPL size 5 - 40 mm
- Actual chest CT scan (\<31 days prior to navigation bronchoscopy), collimation 1 mm, pulmonary window, DICOM format
- Age \> 18 years
- Signed Informed consent form
- Willing and ability to undergone a navigational bronchoscopy
You may not qualify if:
- Unability to undergone navigation bronchoscopy for any reason
- Any malignant disease during last 36 months
- Known central endobronchial lesion of any cause
- HIV-infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ilya Sivokozovlead
Study Sites (6)
Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
Chelyabinsk, Russia
Kurgan Regional Oncological Dispensary
Kurgan, Russia
Central TB Research Institute
Moscow, Russia
P. Hertsen Moscow Oncology Research Institute
Moscow, Russia
National Medical Research Centre for Oncology
Rostov-on-Don, Russia
Tomsk Regional Oncological Dispensary
Tomsk, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ilya Sivokozov, MD PhD
Central TB Research Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Respiratory Endoscopy Department
Study Record Dates
First Submitted
February 4, 2022
First Posted
February 22, 2023
Study Start
February 1, 2022
Primary Completion
December 1, 2024
Study Completion
March 1, 2025
Last Updated
February 6, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share